Targeting Proteasome-Associated Deubiquitinases as a Novel Strategy for the Treatment of Estrogen Receptor-Positive Breast Cancer

Oncogenesis - United States
doi 10.1038/s41389-018-0086-y
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Neoadjuvant Endocrine Therapy for Estrogen Receptor–Positive Breast Cancer

JAMA Oncology
Cancer ResearchOncology
2016English

Therapeutically Targeting Tumor Microenvironment–mediated Drug Resistance in Estrogen Receptor–positive Breast Cancer

Journal of Experimental Medicine
MedicineAllergyImmunology
2018English

Targeting Histones for Degradation in Cancer Cells as a Novel Strategy in Cancer Treatment

Science China Life Sciences
GeneticsMolecular BiologyEnvironmental ScienceBiochemistryBiological SciencesAgricultural
2018English

Development of New Estrogen Receptor-Targeting Therapeutic Agents for Tamoxifen-Resistant Breast Cancer

Future Medicinal Chemistry
Drug DiscoveryMolecular MedicinePharmacology
2013English

Targeting Androgen Receptor in Treating HER2 Positive Breast Cancer

Scientific Reports
Multidisciplinary
2017English

A Modular Analysis of Breast Cancer Reveals a Novel Low-Grade Molecular Signature in Estrogen Receptor-Positive Tumors

Clinical Cancer Research
Cancer ResearchOncology
2006English

Design, Synthesis, Cytocidal Activity and Estrogen Receptor Α Affinity of Doxorubicin Conjugates at 16α-Position of Estrogen for Site-Specific Treatment of Estrogen Receptor Positive Breast Cancer

Steroids
Organic ChemistryMolecular BiologyPharmacologyBiochemistryEndocrinologyClinical Biochemistry
2012English

Estrogen Independent Gene Expression Defines Clinically Relevant Subgroups of Estrogen Receptor Positive Breast Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2014English

Local Estrogen Axis in the Human Bone Microenvironment Regulates Estrogen Receptor-Positive Breast Cancer Cells

Breast Cancer Research
Cancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy